Inference of treatment effect and its regional modifiers using restricted mean survival time in multi-regional clinical trials
Fuente:
arXiv
Saved in:
| Main Authors: | Hua, Kaiyuan, Hong, Hwanhee, Wang, Xiaofei |
|---|---|
| Format: | Preprint |
| Published: |
2024
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Biomarker-Guided Adaptive Enrichment Design with Threshold Detection for Clinical Trials with Time-to-Event Outcome
by: Hua, Kaiyuan, et al.
Published: (2024)
by: Hua, Kaiyuan, et al.
Published: (2024)
Comparing restricted mean survival times in small sample clinical trials using pseudo-observations
by: Jesse, David, et al.
Published: (2024)
by: Jesse, David, et al.
Published: (2024)
Bayesian hierarchical models with calibrated mixtures of g-priors for assessing treatment effect moderation in meta-analysis
by: Wang, Qiao, et al.
Published: (2024)
by: Wang, Qiao, et al.
Published: (2024)
Modeling the restricted mean survival time using pseudo-value random forests
by: Schenk, Alina, et al.
Published: (2024)
by: Schenk, Alina, et al.
Published: (2024)
Bayesian analysis of restricted mean survival time adjusted for covariates using pseudo-observations
by: Orsini, Léa, et al.
Published: (2025)
by: Orsini, Léa, et al.
Published: (2025)
Testing for similarity of dose response in multi-regional clinical trials
by: Dette, Holger, et al.
Published: (2024)
by: Dette, Holger, et al.
Published: (2024)
Integrating tumor burden with survival outcome for treatment effect evaluation in oncology trials
by: Bhandari, Saurabh, et al.
Published: (2025)
by: Bhandari, Saurabh, et al.
Published: (2025)
Doubly robust estimators of the restricted mean time in favor estimands in individual- and cluster-randomized trials
by: Fang, Xi, et al.
Published: (2026)
by: Fang, Xi, et al.
Published: (2026)
Adaptive clinical trial design with delayed treatment effects using elicited prior distributions
by: Salsbury, James, et al.
Published: (2025)
by: Salsbury, James, et al.
Published: (2025)
Estimation of treatment effect in clinical trials of continuous endpoints with retrieved dropouts
by: Kang, Myeongjong, et al.
Published: (2026)
by: Kang, Myeongjong, et al.
Published: (2026)
Causal survival analysis under competing risks using longitudinal modified treatment policies
by: Díaz, Iván, et al.
Published: (2022)
by: Díaz, Iván, et al.
Published: (2022)
Making all pairwise comparisons in multi-arm clinical trials without control treatment
by: Burnett, Thomas, et al.
Published: (2024)
by: Burnett, Thomas, et al.
Published: (2024)
Network Meta‐Analysis of Time‐to‐Event Endpoints With Individual Participant Data Using Restricted Mean Survival Time Regression
by: Kaiyuan Hua, et al.
Published: (2025)
by: Kaiyuan Hua, et al.
Published: (2025)
Nonparametric estimation of an optimal treatment rule with fused randomized trials and missing effect modifiers
by: Williams, Nicholas, et al.
Published: (2025)
by: Williams, Nicholas, et al.
Published: (2025)
Efficiency of nonparametric superiority tests based on restricted mean survival time versus the log-rank test under proportional hazards
by: Magirr, Dominic, et al.
Published: (2024)
by: Magirr, Dominic, et al.
Published: (2024)
On regional treatment effect assessment using robust MAP priors
by: Zhang, Xin, et al.
Published: (2026)
by: Zhang, Xin, et al.
Published: (2026)
Modern approaches for evaluating treatment effect heterogeneity from clinical trials and observational data
by: Lipkovich, Ilya, et al.
Published: (2023)
by: Lipkovich, Ilya, et al.
Published: (2023)
A Unified Inference Method for FROC-type Curves and Related Summary Indices
by: Sun, Jiarui, et al.
Published: (2025)
by: Sun, Jiarui, et al.
Published: (2025)
Assurance Methods for designing a clinical trial with a delayed treatment effect
by: Salsbury, James, et al.
Published: (2023)
by: Salsbury, James, et al.
Published: (2023)
Data fusion methods for the heterogeneity of treatment effect and confounding function
by: Yang, Shu, et al.
Published: (2020)
by: Yang, Shu, et al.
Published: (2020)
Efficient estimation of subgroup treatment effects using multi-source data
by: Wang, Guanbo, et al.
Published: (2024)
by: Wang, Guanbo, et al.
Published: (2024)
An adaptive design for optimizing treatment assignment in randomized clinical trials
by: Zhang, Wei, et al.
Published: (2025)
by: Zhang, Wei, et al.
Published: (2025)
Bayesian joint modelling of longitudinal biomarkers to enable extrapolation of overall survival: an application using larotrectinib trial clinical data
by: Linsell, Louise, et al.
Published: (2025)
by: Linsell, Louise, et al.
Published: (2025)
Estimating causal effects of functional treatments with modified functional treatment policies
by: Jiang, Ziren, et al.
Published: (2026)
by: Jiang, Ziren, et al.
Published: (2026)
Multiple tests for restricted mean time lost with competing risks data
by: Munko, Merle, et al.
Published: (2024)
by: Munko, Merle, et al.
Published: (2024)
Integrating Randomized Controlled Trial and External Control Data Using Balancing Weights: A Comparison of Estimands and Estimators
by: Wang, Peijin, et al.
Published: (2025)
by: Wang, Peijin, et al.
Published: (2025)
Factors affecting power in stepped wedge trials when the treatment effect varies with time
by: Kenny, Avi, et al.
Published: (2025)
by: Kenny, Avi, et al.
Published: (2025)
Restricted mean survival times for comparing grouped survival data: a Bayesian nonparametric approach
by: Riva-Palacio, Alan, et al.
Published: (2024)
by: Riva-Palacio, Alan, et al.
Published: (2024)
Using shrinkage methods to estimate treatment effects in overlapping subgroups in randomized clinical trials with a time-to-event endpoint
by: Wolbers, Marcel, et al.
Published: (2024)
by: Wolbers, Marcel, et al.
Published: (2024)
Doubly protected estimation for survival outcomes utilizing external controls for randomized clinical trials
by: Gao, Chenyin, et al.
Published: (2024)
by: Gao, Chenyin, et al.
Published: (2024)
Restricted mean time lost for survival and competing risks data using mets in R
by: Scheike, Thomas Harder, et al.
Published: (2026)
by: Scheike, Thomas Harder, et al.
Published: (2026)
One-sample survival tests in the presence of non-proportional hazards in oncology clinical trials
by: Szurewsky, Chloé, et al.
Published: (2025)
by: Szurewsky, Chloé, et al.
Published: (2025)
The causal effects of modified treatment policies under network interference
by: Balkus, Salvador V., et al.
Published: (2024)
by: Balkus, Salvador V., et al.
Published: (2024)
Identification and estimation of mediational effects of longitudinal modified treatment policies
by: Gilbert, Brian, et al.
Published: (2024)
by: Gilbert, Brian, et al.
Published: (2024)
Variable importance measures for heterogeneous treatment effects with survival outcome
by: Ziersen, Simon Christoffer, et al.
Published: (2024)
by: Ziersen, Simon Christoffer, et al.
Published: (2024)
Doubly robust average treatment effect estimation for survival data
by: Lee, Byeonghee, et al.
Published: (2025)
by: Lee, Byeonghee, et al.
Published: (2025)
Analysis of stepped wedge cluster randomized trials in the presence of a time-varying treatment effect
by: Kenny, Avi, et al.
Published: (2021)
by: Kenny, Avi, et al.
Published: (2021)
Covariate adjustment for linear models in estimating treatment effects in randomised clinical trials. Some useful theory to guide simulation
by: Senn, Stephen, et al.
Published: (2025)
by: Senn, Stephen, et al.
Published: (2025)
Separable pathway effects of semi-competing risks using multi-state models
by: Deng, Yuhao, et al.
Published: (2023)
by: Deng, Yuhao, et al.
Published: (2023)
A nonparametric framework for treatment effect modifier discovery in high dimensions
by: Boileau, Philippe, et al.
Published: (2023)
by: Boileau, Philippe, et al.
Published: (2023)
Similar Items
-
Biomarker-Guided Adaptive Enrichment Design with Threshold Detection for Clinical Trials with Time-to-Event Outcome
by: Hua, Kaiyuan, et al.
Published: (2024) -
Comparing restricted mean survival times in small sample clinical trials using pseudo-observations
by: Jesse, David, et al.
Published: (2024) -
Bayesian hierarchical models with calibrated mixtures of g-priors for assessing treatment effect moderation in meta-analysis
by: Wang, Qiao, et al.
Published: (2024) -
Modeling the restricted mean survival time using pseudo-value random forests
by: Schenk, Alina, et al.
Published: (2024) -
Bayesian analysis of restricted mean survival time adjusted for covariates using pseudo-observations
by: Orsini, Léa, et al.
Published: (2025)